Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Keros Therapeutics, Inc. (KROS)

NASDAQ

$11.35

$-0.20

(-1.73%)

Pre-Market

Keros Therapeutics, Inc. (KROS) Live Price Chart

Last updated: ⁦2026-09-09 10:17:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Keros Therapeutics, Inc. (KROS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11.35, with a market capitalization of $224.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.69 to $22.55. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$224.44M
Open	$11.55
Day's High	$88.80
Day's Low	$9.12
Previous Close	$11.17
Volume	700.00
Average Volume	238.00K
P/E Ratio	--
52-Week High	$22.55
52-Week Low	$9.69
Dividend Yield	--
Earnings Date	--

Keros Therapeutics, Inc. (KROS) Pre-Market Stock Price

Keros Therapeutics, Inc. (KROS) is trading at $11.35 in pre-market trading as of 2026-09-09 09:00:00, up 1.58% ($0.18) from the previous close of $11.17

Pre-market trading shows how investors are pricing KROS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Keros Therapeutics, Inc. (KROS) 7-Day Stock Price Change

Over the past seven days, Keros Therapeutics, Inc. (KROS) moved from $11.03 to $11.35, representing a gain of 2.86% ($0.32).

The stock traded between $10.58 and $11.55 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 141.41 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

KROS 52-Week Price Position

Position in Range: 12.9%

52W Low$9.69

52W High$22.55

KROS is currently trading at $11.35, placing it 12.9% of the way from its 52-week low of $9.69 to its 52-week high of $22.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Keros Therapeutics, Inc. (KROS)?

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Keros Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	92
Exchange	NASDAQ
Company Website	https://www.kerostx.com

How to Buy Keros Therapeutics, Inc. (KROS) Stock on MEXC

Eligible investors can buy real shares of Keros Therapeutics, Inc. (KROS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KROS and Place Your Order

Open the RealStocks trading page and search for KROS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Keros Therapeutics, Inc. (KROS) stock price today?

Keros Therapeutics, Inc. (KROS) is currently trading at $ 11.35, up 1.58% ($0.18) from the previous close of $ 11.17. Intraday prices update in real time during regular trading hours.

2.Is KROS stock going up or down today?

As of 2026-09-09 09:00:00, KROS is trading at $ 11.35, up 1.58% ($0.18) from its previous close of $ 11.17. The stock has traded between $ 9.12 and $ 88.80 during today’s regular session. Past price movements do not guarantee future results.

3.What is KROS pre-market price?

As of 2026-09-09 09:00:00, KROS is trading at $ 11.35 in pre-market trading, up 1.58% ($0.18) from the previous close of $ 11.17. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KROS after-hours price?

As of 2026-09-09 09:00:00, KROS is trading at $ 11.55 in after-hours trading, up 3.38% ($0.38) from the regular-session close of $ 11.17. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KROS stock trading now?

KROS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KROS sit relative to its 52-week high and low?

Over the past 52 weeks, KROS has traded between a low of $ 9.69 and a high of $ 22.55. At $ 11.35, the stock is positioned 12.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Keros Therapeutics, Inc. in?

Keros Therapeutics, Inc. (KROS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Keros Therapeutics, Inc.'s market capitalization and where is it listed?

Keros Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 224.44M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KROS valued in terms of P/E ratio and EPS?

KROS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Keros Therapeutics, Inc. pay a dividend?

Keros Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.